Forest CEO: Aptalis a `Compelling Opportunity'

Jan. 8 (Bloomberg) -- Brent Saunders, chief executive officer of Forest Laboratories Inc., talks about the company's agreement to acquire Aptalis Pharma for $2.9 billion in cash. Aptalis is a closely held company whose shareholders include investment firm TPG Capital. Saunders speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

James Tisch: Fed Should Have Raised Rates Years Ago
58:01 - James Tisch, president and chief executive officer at Loews Corp., discusses the Federal Reserve's approach to raising interest rates and the effects of quantitative easing on the U.S. economy. He speaks on "Bloomberg ‹GO›." (Source: Bloomberg)
  • Loews CEO Tisch : Fed 'Woefully Behind' in Raising Rates
  • Loews CEO Tisch: Oil Will Go Back to $65-$70 a Barrel
  • Brazil's Economy Shrinks More Than Forecast